Emergence of Vancomycin Intermediate Staphylococcus aureus (VISA) in Clinical Isolates of Methicillin Resistant S. aureus from South Western Region of Nigeria
D. Olusoga Ogbolu, O. A. Terry Alli, L. A Bello & A. O. Ibrahim · International Journal of TROPICAL DISEASE & Health · 2015
Aim: Vancomycin has been widely used in the treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA). The emergence of vancomycin- intermediate and -resistant Staphylococcus aureus (VISA and VRSA, respectively) in various parts of the world has been re...
Open access
Research Article
10.9734/IJTDH/2015/20642